KROS SG&A Expense Growth
Keros Therapeutics Inc · SG&A Expense Growth
KROS SG&A Expense Growth
Latest reported14.96%period ending
KROS FY SG&A Growth (YoY) (0.00% → 14.96%)
Latest values, visible window
High-resolution chart · PNG
KROS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.9556% | |
| 16.9949% | |
| 26.554% | |
| 29.0436% | |
| 74.9508% | |
| 282.9146% | |
| 101.519% | |
| 0% |